skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
Join Scrip's Mandy Jackson and Jessica Merrill and Derek Burkhard, director of financial content for Datamonitor Healthcare and Biomedtracker, for a discussion about what toll the pandemic took on the biopharmaceutical industry and what to expect from the fourth quarter/full year financial results coming out. They also draw on the recent J.P. Morgan Healthcare Conference and their conversations with company execs to consider what challenges lie ahead as industry moves past the pandemic and focuses on long-term growth.  


Read also


Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: